Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Irritable Bowel Syndrome, July 2021

Free Subscription


Abstracts

Retrieve all available abstracts of the following 74 articles:
HTML format


 

Single Articles

  1. ZHAO Q, Fang Y, Yan C, Gao J, et al
    Effects of linaclotide in the treatment of chronic constipation and irritable bowel syndrome with constipation: a meta-analysis.
    Z Gastroenterol. 2021 Jul 2. doi: 10.1055/a-1491-1784.
    PubMed    
    Abstract available

  2. MACK I, Schwille-Kiuntke J, Mazurak N, Niesler B, et al
    A non-viable probiotic in irritable bowel syndrome - a randomized, double-blind, placebo-controlled, multi-center study.
    Clin Gastroenterol Hepatol. 2021 Jun 29. pii: S1542-3565(21)00692.
    PubMed    
    Abstract available

  3. SHIN A, Chang L
    The Transition from Rome III to Rome IV Irritable Bowel Syndrome: What We Gain and Lose.
    Clin Gastroenterol Hepatol. 2021 Jun 29. pii: S1542-3565(21)00696.
    PubMed    


  4. KOOCHAKPOOR G, Salari-Moghaddam A, Keshteli AH, Esmaillzadeh A, et al
    Association of Coffee and Caffeine Intake With Irritable Bowel Syndrome in Adults.
    Front Nutr. 2021;8:632469.
    PubMed    
    Abstract available

  5. LIU G, Li S, Chen N, Zhao Z, et al
    Inter-hemispheric Functional Connections Are More Vulnerable to Attack Than Structural Connection in Patients With Irritable Bowel Syndrome.
    J Neurogastroenterol Motil. 2021;27:426-435.
    PubMed    
    Abstract available

  6. FRIESEN C, Colombo J, Schurman J
    Update on the Role of Allergy in Pediatric Functional Abdominal Pain Disorders: A Clinical Perspective.
    Nutrients. 2021;13.
    PubMed    
    Abstract available

  7. LOPEZ-GOMEZ L, Szymaszkiewicz A, Zielinska M, Abalo R, et al
    Nutraceuticals and Enteric Glial Cells.
    Molecules. 2021;26.
    PubMed    
    Abstract available

  8. GALVEZ-SANCHEZ CM, Montoro CI, Moreno-Padilla M, Reyes Del Paso GA, et al
    Effectiveness of Acceptance and Commitment Therapy in Central Pain Sensitization Syndromes: A Systematic Review.
    J Clin Med. 2021;10.
    PubMed    
    Abstract available

  9. WANG X, Fukui H, Ran Y, Xu X, et al
    Probiotic Bifidobacterium bifidum G9-1 Has a Preventive Effect on the Acceleration of Colonic Permeability and M1 Macrophage Population in Maternally Separated Rats.
    Biomedicines. 2021;9.
    PubMed    
    Abstract available

  10. SIMON E, Calinoiu LF, Mitrea L, Vodnar DC, et al
    Probiotics, Prebiotics, and Synbiotics: Implications and Beneficial Effects against Irritable Bowel Syndrome.
    Nutrients. 2021;13.
    PubMed    
    Abstract available

  11. YAN R, Andrew L, Marlow E, Kunaratnam K, et al
    Dietary Fibre Intervention for Gut Microbiota, Sleep, and Mental Health in Adults with Irritable Bowel Syndrome: A Scoping Review.
    Nutrients. 2021;13.
    PubMed    
    Abstract available

  12. SAVIANO A, Brigida M, Migneco A, Gunawardena G, et al
    Lactobacillus Reuteri DSM 17938 (Limosilactobacillus reuteri) in Diarrhea and Constipation: Two Sides of the Same Coin?
    Medicina (Kaunas). 2021;57.
    PubMed    
    Abstract available

  13. CARROCCIO A, Soresi M, Chiavetta M, La Blasca F, et al
    Frequency and Clinical Aspects of Neurological and Psychiatric Symptoms in Patients with Non-Celiac Wheat Sensitivity.
    Nutrients. 2021;13.
    PubMed    
    Abstract available

  14. AHLUWALIA B, Iribarren C, Magnusson MK, Sundin J, et al
    A Distinct Faecal Microbiota and Metabolite Profile Linked to Bowel Habits in Patients with Irritable Bowel Syndrome.
    Cells. 2021;10.
    PubMed    
    Abstract available

  15. DONG LW, Sun XN, Ma ZC, Fu J, et al
    Increased Vdelta1gammadeltaT cells predominantly contributed to IL-17 production in the development of adult human post-infectious irritable bowel syndrome.
    BMC Gastroenterol. 2021;21:271.
    PubMed    
    Abstract available

  16. GANDHI A, Shah A, Jones MP, Koloski N, et al
    Methane positive small intestinal bacterial overgrowth in inflammatory bowel disease and irritable bowel syndrome: A systematic review and meta-analysis.
    Gut Microbes. 2021;13:1933313.
    PubMed    
    Abstract available

  17. WLODARCZYK J, Szalwinska P, Wasniewska A, Fichna J, et al
    Experimental therapies in Irritable Bowel Syndrome.
    Folia Med Cracov. 2021;61:5-17.
    PubMed    
    Abstract available

  18. UCAR IC, Esen F, Turhan SA, Oguz H, et al
    Corneal neuropathic pain in irritable bowel syndrome: clinical findings and in vivo corneal confocal microscopy.
    Graefes Arch Clin Exp Ophthalmol. 2021 Jun 29. pii: 10.1007/s00417-021-05269.
    PubMed    
    Abstract available

  19. ESLAMPOUR E, Ghanadi K, Aghamohammadi V, Kazemi AM, et al
    "Association between dietary inflammatory index (DII) and risk of irritable bowel syndrome: a case-control study".
    Nutr J. 2021;20:60.
    PubMed    
    Abstract available

  20. VAN LANEN AS, de Bree A, Greyling A
    Correction to: Efficacy of a low-FODMAP diet in adult irritable bowel syndrome: a systematic review and meta-analysis.
    Eur J Nutr. 2021 Jun 28. pii: 10.1007/s00394-021-02620.
    PubMed    


  21. LAJOIE F, Rousseau G, Blanquet-Diot S, Etienne-Mesmin L, et al
    [Irritable bowel syndrome: Role of gut microbiota].
    Med Sci (Paris). 2021;37.
    PubMed    
    Abstract available

  22. LIU Y, Li W, Yang H, Zhang X, et al
    Leveraging 16S rRNA Microbiome Sequencing Data to Identify Bacterial Signatures for Irritable Bowel Syndrome.
    Front Cell Infect Microbiol. 2021;11:645951.
    PubMed    
    Abstract available

  23. CHEN J, Chen X, Xie Y, Sun Y, et al
    Irritable Bowel Syndrome and Migraine: Evidence from Mendelian Randomization Analysis in the UK Biobank.
    Expert Rev Gastroenterol Hepatol. 2021.
    PubMed    
    Abstract available

  24. GAJDOS P, Roman N, Toth-Kiraly I, Rigo A, et al
    Functional gastrointestinal symptoms and increased risk for orthorexia nervosa.
    Eat Weight Disord. 2021 Jun 25. pii: 10.1007/s40519-021-01242.
    PubMed    
    Abstract available

  25. EL-SALHY M, Patcharatrakul T, Gonlachanvit S
    Fecal microbiota transplantation for irritable bowel syndrome: An intervention for the 21(st) century.
    World J Gastroenterol. 2021;27:2921-2943.
    PubMed    
    Abstract available

  26. TAN X, Pei W, Xie C, Wang Z, et al
    Tongxie Anchang Decoction Relieves Visceral Hypersensitivity in Diarrhea-Predominant Irritable Bowel Syndrome Rats by Regulating the NGF/TrkA Signaling Pathway.
    Evid Based Complement Alternat Med. 2021;2021:6679348.
    PubMed    
    Abstract available

  27. STANCULETE MF, Chiarioni G, Dumitrascu DL, Dumitrascu DI, et al
    Disorders of the brain-gut interaction and eating disorders.
    World J Gastroenterol. 2021;27:3668-3681.
    PubMed    
    Abstract available

  28. SEBASTIAN DOMINGO JJ
    Irritable bowel syndrome.
    Med Clin (Barc). 2021 Jul 5. pii: S0025-7753(21)00334.
    PubMed    
    Abstract available

  29. MORENO LO, Sanchez PN, Abalo R
    Lipidomics As Tools For Finding Biomarkers Of Intestinal Pathology: From Irritable Bowel Syndrome To Colorectal Cancer.
    Curr Drug Targets. 2021 Jul 7. pii: CDT-EPUB-116527.
    PubMed    
    Abstract available

  30. PICARELLI A, Greco N, Sciuttini F, Marini C, et al
    High consumption of Nickel-containing foods and IBS-like disorders: late events in a gluten-free diet.
    Ecotoxicol Environ Saf. 2021;222:112492.
    PubMed    
    Abstract available

  31. AZAD AK, Doolaanea AA, Al-Mahmood SMA, Kennedy JF, et al
    Electro-hydrodynamic assisted synthesis of lecithin-stabilized peppermint oil-loaded alginate microbeads for intestinal drug delivery.
    Int J Biol Macromol. 2021 Jul 5. pii: S0141-8130(21)01456.
    PubMed    
    Abstract available

  32. EL-SALHY M, Hausken T, Hatlebakk JG
    Current status of fecal microbiota transplantation for irritable bowel syndrome.
    Neurogastroenterol Motil. 2021 Jul 8:e14157. doi: 10.1111/nmo.14157.
    PubMed    
    Abstract available

  33. PARK J, Ko SJ, Han G, Kim K, et al
    Gwakhyangjeonggi-san for irritable bowel syndrome: A protocol for systematic review and meta-analysis.
    Medicine (Baltimore). 2021;100:e26635.
    PubMed    
    Abstract available

  34. LYUTAKOV I, Nakov R, Valkov H, Vatcheva-Dobrevska R, et al
    Serum Levels of Fibroblast Growth Factor 19 Correlate with the Severity of Diarrhea and Independently from Intestinal Inflammation in Patients with Inflammatory Bowel Disease or Microscopic Colitis.
    Turk J Gastroenterol. 2021;32:374-381.
    PubMed    
    Abstract available

  35. SAINI S, Narang M, Srivastava S, Shah D, et al
    Behavioral Intervention in Children with Functional Abdominal Pain Disorders: A Promising Option.
    Turk J Gastroenterol. 2021;32:443-450.
    PubMed    
    Abstract available

  36. GUO J, Lu G, Chen L, Geng H, et al
    Regulation of serum microRNA expression by acupuncture in patients with diarrhea-predominant irritable bowel syndrome.
    Acupunct Med. 2021 Jul 7:9645284211027892. doi: 10.1177/09645284211027892.
    PubMed    
    Abstract available

  37. ADLER AA, Ciccotti HR, Trivitt SJH, Watson RCJ, et al
    What's new in travelers' diarrhea: Updates on epidemiology, diagnostics, treatment, and long-term consequences.
    J Travel Med. 2021 Jul 6. pii: 6316240. doi: 10.1093.
    PubMed    
    Abstract available

  38. NAN JF, Meng PT, Zong NN, Zhang JC, et al
    [Dynamic characteristics of brain networks in patients with irritable bowel syndrome based on functional magnetic resonance imaging].
    Sheng Li Xue Bao. 2021;73:355-368.
    PubMed    
    Abstract available

  39. ZHENG L, Lu W, Xiao Q, Lai Y, et al
    Assessing the post-treatment therapeutic effect of pinaverium in irritable bowel syndrome: a randomized controlled trial.
    Sci Rep. 2021;11:13894.
    PubMed    
    Abstract available

  40. MCCRONE P, Everitt H, Landau S, Little P, et al
    Cost effectiveness of therapist delivered cognitive behavioural therapy and web-based self-management in irritable bowel syndrome: the ACTIB randomised trial.
    BMC Gastroenterol. 2021;21:276.
    PubMed    
    Abstract available

  41. KEEFER L, Ko CW, Ford AC
    AGA Clinical Practice Update on Management of Chronic Gastrointestinal Pain in Disorders of Gut-Brain Interaction: Expert Review.
    Clin Gastroenterol Hepatol. 2021 Jul 3. pii: S1542-3565(21)00717.
    PubMed    
    Abstract available

  42. MELCHIOR C, Algera J, Colomier E, Tornblom H, et al
    Food avoidance and restriction in irritable bowel syndrome: relevance for symptoms, quality of life and nutrient intake.
    Clin Gastroenterol Hepatol. 2021 Jul 3. pii: S1542-3565(21)00715.
    PubMed    
    Abstract available

  43. SCHNEIDER E, Sabate JM, Bouchoucha M, Debras C, et al
    FODMAP Consumption by Adults from the French Population-Based NutriNet-Sante Cohort.
    J Nutr. 2021 Jul 5. pii: 6315834. doi: 10.1093.
    PubMed    
    Abstract available

  44. WANG T, Li L, Li S, Zhao H, et al
    Clostridium butyricum relieve the visceral hypersensitivity in mice induced by Citrobacter rodentium infection with chronic stress.
    PeerJ. 2021;9:e11585.
    PubMed    
    Abstract available

  45. XING Y, Xue S, Wu J, Zhou J, et al
    Serum Exosomes Derived from Irritable Bowel Syndrome Patient Increase Cell Permeability via Regulating miR-148b-5p/RGS2 Signaling in Human Colonic Epithelium Cells.
    Gastroenterol Res Pract. 2021;2021:6655900.
    PubMed    
    Abstract available

  46. NASERI K, Dabiri H, Rostami-Nejad M, Yadegar A, et al
    Influence of low FODMAP-gluten free diet on gut microbiota alterations and symptom severity in Iranian patients with irritable bowel syndrome.
    BMC Gastroenterol. 2021;21:292.
    PubMed    
    Abstract available

  47. WALTERS JRF
    The role of bile acids and their TGR5 receptor in irritable bowel syndrome and diarrhoea.
    Dig Liver Dis. 2021 Jul 11. pii: S1590-8658(21)00330.
    PubMed    
    Abstract available

  48. WALLEN H, Lindfors P, Andersson E, Hedman-Lagerlof E, et al
    Return on investment of internet delivered exposure therapy for irritable bowel syndrome: a randomized controlled trial.
    BMC Gastroenterol. 2021;21:289.
    PubMed    
    Abstract available

  49. YOON SY, Shin J, Heo SJ, Chang JS, et al
    Irritable bowel syndrome and subsequent risk of Parkinson's disease: a nationwide population-based matched-cohort study.
    J Neurol. 2021 Jul 13. pii: 10.1007/s00415-021-10688.
    PubMed    
    Abstract available

  50. RAO SSC, Coss-Adame E, Yan Y, Erdogan A, et al
    Sensory Adaptation Training or Escitalopram for IBS With Constipation and Rectal Hypersensitivity: A Randomized Controlled Trial.
    Clin Transl Gastroenterol. 2021;12:e00381.
    PubMed    
    Abstract available

  51. SIMONS M, Taft TH, Doerfler B, Ruddy JS, et al
    Narrative review: Risk of eating disorders and nutritional deficiencies with dietary therapies for irritable bowel syndrome.
    Neurogastroenterol Motil. 2021 Jul 13:e14188. doi: 10.1111/nmo.14188.
    PubMed    
    Abstract available

  52. BLACK CJ, Ford AC
    Best management of irritable bowel syndrome.
    Frontline Gastroenterol. 2020;12:303-315.
    PubMed    
    Abstract available

  53. RONDEAU LE, De Palma G, Caminero A
    The food, the bug, and the ugly: A recipe for food-induced gut pain.
    Allergy. 2021 Jul 22. doi: 10.1111/all.15018.
    PubMed    
    Abstract available

  54. WELANDER NZ, Olivo G, Pisanu C, Rukh G, et al
    Migraine and gastrointestinal disorders in middle and old age: A UK Biobank study.
    Brain Behav. 2021 Jul 21. doi: 10.1002/brb3.2291.
    PubMed    
    Abstract available

  55. ZHAO Y, Siri S, Feng B, Pierce DM, et al
    Toward Elucidating the Physiological Impacts of Residual Stresses in the Colorectum.
    J Biomech Eng. 2021 Jul 21. pii: 1114807. doi: 10.1115/1.4051846.
    PubMed    
    Abstract available

  56. KHUDA BAKHSH Z, Khan R, Bashir K
    Abdominal Pain Caused by Occlusion of the Celiac Trunk and Superior Mesenteric Artery in Addition to Irritable Bowel Syndrome: Case Series and Literature Review.
    Cureus. 2021;13:e15729.
    PubMed    
    Abstract available

  57. LINDHOLM M, Godskesen LE, Manon-Jensen T, Kjeldsen J, et al
    Endotrophin and C6Ma3, serological biomarkers of type VI collagen remodelling, reflect endoscopic and clinical disease activity in IBD.
    Sci Rep. 2021;11:14713.
    PubMed    
    Abstract available

  58. IZUNO S, Yoshihara K, Sudo N
    Role of Gut Microbiota in the Pathophysiology of Stress-Related Disorders: Evidence from Neuroimaging Studies.
    Ann Nutr Metab. 2021 Jul 19:1-7. doi: 10.1159/000517420.
    PubMed    
    Abstract available

  59. CUNNINGHAM AL, Esarte Palomero O, Voss BJ, Trent MS, et al
    IBS Therapeutic has Broad Spectrum Antimicrobial Activity.
    Antimicrob Agents Chemother. 2021 Jul 19:AAC0044321. doi: 10.1128/AAC.00443.
    PubMed    
    Abstract available

  60. JIN X, Gharibani P, Yin J, Chen JDZ, et al
    Neuro-Immune Modulation Effects of Sacral Nerve Stimulation for Visceral Hypersensitivity in Rats.
    Front Neurosci. 2021;15:645393.
    PubMed    
    Abstract available

  61. ROKKAS T, Ekmektzoglou K, Niv Y
    Comparative effectiveness of 5-hydroxytryptamine 3 receptor antagonists in irritable bowel syndrome: a network meta-analysis of randomized controlled studies.
    Ann Gastroenterol. 2021;34:535-546.
    PubMed    
    Abstract available

  62. SCHWILLE-KIUNTKE J, Rudlin SL, Junne F, Enck P, et al
    Illness perception and health care use in individuals with irritable bowel syndrome: results from an online survey.
    BMC Fam Pract. 2021;22:154.
    PubMed    
    Abstract available

  63. NELSON AD, Black CJ, Houghton LA, Lugo-Fagundo NS, et al
    Editorial: recognising the efficacy of licensed drug therapies for irritable bowel syndrome on bloating-a step in the right direction for targeted treatment? Authors' reply.
    Aliment Pharmacol Ther. 2021;54:198-199.
    PubMed    


  64. TALLEY NJ, Walker MM, Agreus L, Andreasson A, et al
    Editorial: tobacco use in functional dyspepsia-another smoking gun? Authors' reply.
    Aliment Pharmacol Ther. 2021;54:79.
    PubMed    


  65. WOO MMK, Andrews CN
    Editorial: tobacco use in functional dyspepsia-another smoking gun?
    Aliment Pharmacol Ther. 2021;54:78.
    PubMed    


  66. KOLOSKI NA, Jones M, Walker MM, Keely S, et al
    Sleep disturbances in the irritable bowel syndrome and functional dyspepsia are independent of psychological distress: a population-based study of 1322 Australians.
    Aliment Pharmacol Ther. 2021 Jul 11. doi: 10.1111/apt.16500.
    PubMed    
    Abstract available

  67. KESZTHELYI D
    Irritable Bowel Syndrome and Functional Dyspepsia: Different Ends of the Same Spectrum of Intestinal Barrier Dysfunction?
    Am J Gastroenterol. 2021;116:1556.
    PubMed    


  68. DEUTSCH D, Bouchoucha M, Devroede G, Raynaud JJ, et al
    Functional gastrointestinal disorders as predictors of suicidal ideation. An observational study.
    Eur J Gastroenterol Hepatol. 2021 Jul 6. pii: 00042737-900000000-97181.
    PubMed    
    Abstract available

  69. REINISCH W
    PEG and mucosal biofilms in irritable bowel syndrome and ulcerative colitis.
    Gastroenterology. 2021 Jun 24. pii: S0016-5085(21)03167.
    PubMed    


  70. MIHINDUKULASURIYA KA, Mars RAT, Johnson AJ, Ward T, et al
    Multi-omics analyses show disease, diet, and transcriptome interactions with the virome.
    Gastroenterology. 2021 Jul 7. pii: S0016-5085(21)03234.
    PubMed    
    Abstract available

  71. CORDOVA J, Biank V, Black E, Leikin J, et al
    Urinary Cannabis Metabolite Concentrations in Cannabis Hyperemesis Syndrome.
    J Pediatr Gastroenterol Nutr. 2021 Jun 28. pii: 00005176-900000000-95618.
    PubMed    
    Abstract available

  72. BUSELLI R, Veltri A, Corsi M, Marino R, et al
    Irritable Bowel Syndrome prevalence and work ability in a sample of healthcare workers exposed to occupational stress.
    J Psychosom Res. 2021;148:110566.
    PubMed    
    Abstract available

  73. TAFT TH, Keszthelyi D, Van Oudenhove L
    A Review of Irritable Bowel Syndrome.
    JAMA. 2021;326:189.
    PubMed    


  74. CAMILLERI M
    A Review of Irritable Bowel Syndrome-Reply.
    JAMA. 2021;326:189-190.
    PubMed    



Thank you for your interest in scientific medicine.


AMEDEO Irritable Bowel Syndrome is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design:


;